Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Left ventricular assist devices (LVADs) are currently used as destination therapy or bridge to heart transplantation in patients with advanced chronic heart failure (CHF). It has been proved to reduce mortality and symptoms in these patients. Patients with advanced CHF are known to have increased risk of ventricular arrhythmias (ventricular tachycardia or ventricular fibrillation (VF)) despite the presence of LVAD. We report the case of patients with ongoing VF during LVAD treatment while being awake and aware. We discuss the challenges introduced along with the increasing use of LVAD treatment. The decision whether a patient with LVAD automatically should have an implantable cardioverter-defibrillator is challenging. Randomised trials are warranted to shed light on these challenging decisions. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.


Ingrid Hell Mott, Steen Hvitfeldt Poulsen, Brian Bridal Løgstrup. Awake and aware with ongoing ventricular fibrillation during LVAD treatment: is it possible? BMJ case reports. 2020 Apr 22;13(4)

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 32327464

View Full Text